A survival analysis of 293 patients with acute myeloid leukemia taken from Verhaak et al. [20] revealed an association between event-free survival and RUNX1 expression: a reduced expression of RUNX1 was associated with better outcome (Figure 4D). This evidence concerns the gene RUNX1 and acute myeloid leukemia.